Dr. Rajachendra Shekher Tumma, MD

Dr. Tumma practices at North Mississippi Medical Center-Tupelo in Tupelo, Mississippi, part of North Mississippi Health Services.

Dr. Tumma's NPI, 1043657455, was assigned on May 24, 2013. Dr. Tumma holds Louisiana license 302668.

Dr. Tumma's primary practice is North Mississippi Medical Center-Tupelo, at 830 S Gloster Street, Tupelo, MS 38801 in Lee County. The practice phone is (662) 377-6608.

Dr. Tumma's primary practice is North Mississippi Medical Center-Tupelo in Tupelo, Mississippi, part of North Mississippi Health Services. Dr. Tumma is also affiliated with University of Mississippi Medical Center. The medical group on file is North Mississippi Medical Center. Dmand AI also links Dr. Tumma to 1 more hospital, 5 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tumma practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tumma's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Tumma is licensed in Louisiana.

CMS data shows 1,056 Medicare services from Dr. Tumma across 4 procedure codes in 2024, for 293 Medicare patients. Medicare paid $95,691 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 293 Medicare patients who saw Dr. Tumma in 2024. The largest group is 75 to 84, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tumma's median patient age at 63, with 52% women.

In 2024, Dr. Tumma wrote 464 Medicare Part D claims for 155 patients. 92% of them were for generic drugs. CMS names the drug for 239 of them, across 12 drugs with 11 or more claims each, at $1,146 in total drug cost. In 2023, CMS named 139 claims across 6 drugs.

Dr. Tumma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Dr. Tumma from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $94.